País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
CEFALEXIN DIHYDROSTREPTOMYCIN SULFATE
Bimeda Chemicals
QJ51RD01
intramammary Suspension
Antibacterial
Bovine
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Kefamast Lactating Cow Intramammary suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Intramammary Suspension 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Lactating cow. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mastitis caused by organisms susceptible to the combination of cephalexin and dihydrostreptomycin in lactating cows. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each 10ml syringe contains: Active substances Cephalexin (Anhydrous) 500 mg Dihydrostreptomycin 500 mg (as Dihydrostreptomycin Sulphate). IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/04/2012_ _CRN 7012593_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION (S) FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Operators should avoid contact with this preparation as occasionally skin allergy may occur. Penicillins and cephalosporins may cause hypersensitivity following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know that you are sensitized, or if you have been advised not to work with such preparations. Handle this product with care to avoid exposure. If you develop symptoms such as a skin rash following exposure, seek medical advice and show this warning to your d Leer el documento completo